GoodRx: The 10 most expensive drugs approved in 2018

1. Takhzyro — $573,820 (Hereditary angioedema*)
2. Tegsedi — $449,800 (Hereditary polyneuropathy)
3. Vitrakvi — $399,069 (Solid tumors)
4. Tibsovo — $317,733 (Acute myeloid leukemia)
5. Galafold — $315,250 (Fabry disease)
6. Symdeko — $292,000 (Cystic fibrosis)
7. Xospata — $273,750 (Acute myeloid leukemia
8. Lobrena — $195,345 (Lung cancer)
9. Palynziq — $178,120 (Phenylketonuria)
10. Talzenna — $177,390 (Breast cancer)

Notes: Primary indication of drug
Source: GoodRx
Source URL: https://www.goodrx.com/blog/prescription-drugs-approved-in-2...

Printer-friendly versionSend to friendmore...